Brazil maps orthopaedics testing network:
This article was originally published in Clinica
The Brazilian health surveillance agency, Anvisa, has published the results of a survey of the research being performed by orthopaedics testing centres. The aim of the exercise was to map these nationally, their activities and the techniques used. Input from the tests performed are used by the national network of healthcare laboratories - Rede Brasileira de Laboratorios Analiticos de Saude (Reblas) - to establish testing standards and quality control systems. 23 centres participated in the survey, located mainly in the southeast region, centred around Sao Paulo. Of the 191 tests surveyed, eight are not performed by any of the participating centres.
You may also be interested in...
Teva plans to begin appeal proceedings, the firm has told Generics Bulletin, after being fined €60.5m ($72m) by the European Commission over an historic “pay-for-delay” arrangement covering subsidiary firm Cephalon’s Provigil (modafinil).
SK set for Korean trial with vaccine, as Biological E begins human trials of Baylor vaccine. Meanwhile, DongWha gets a Phase II nod for potential drug, and Celltrion progesses with Phase II regdanvimab trial.
UK start up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country.